Evidence map›Paper›PMID 40258145›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Rab32 regulates Golgi structure and cell migration through Protein Kinase A-mediated phosphorylation of Optineurin.

Katherine M Johnson, Maxwell G Marley, Kristina Drizyte-Miller, Jing Chen, Hong Cao, Nourhan Mostafa, Micah B Schott, Mark A McNiven, Gina L Razidlo

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Rab32 regulates Golgi structure and cell migration through Protein Kinase A-mediated phosphorylation of Optineurin.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katherine M JohnsonDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905.
Maxwell G MarleyDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905.
Kristina Drizyte-MillerMayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905.
Jing ChenDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905.
Hong CaoDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905.
Nourhan MostafaDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198.
Micah B SchottDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905.
Mark A McNivenDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905.
Gina L RazidloDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-9042-2738

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Lila J. Rutten · 1985 to 2026
$151.3M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI Samar Ibrahim · 2009 to 2026
$22.2M
Project 4: ImmunovirotherapyP50CA210964 · NCI · MAYO CLINIC ROCHESTER · PI Zongming Eric Chen · 2018 to 2026
$20.5M
Fast super-resolution/confocal microscopy for GI cell biologyS10OD028633 · OD · MAYO CLINIC ROCHESTER · PI MC NIVEN, MARK A. · 2021 to 2021
$600k
HHS | NIH | National Cancer Institute (NCI) P30CA015083HHS | NIH | National Cancer Institute (NCI) P50CA210964HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) P30DK084567HHS | NIH | NIH Office of the Director (OD) S10OD028633NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA210964NIDDK NIH HHS P30 DK084567NIH HHS S10 OD028633
6 · The paper itself

Abstract

Rab32 is a small GTPase and molecular switch implicated in vesicular trafficking. Rab32 is also an A-Kinase Anchoring Protein (AKAP), which anchors cAMP-dependent Protein Kinase (PKA) to specific subcellular locations and specifies PKA phosphorylation of nearby substrates. Surprisingly, we found that a form of Rab32 deficient in PKA binding (Rab32 L188P) relocalized away from the Golgi apparatus and induced a marked disruption in Golgi organization, assembly, and dynamics. Although Rab32 L188P did not cause a global defect in PKA activity, our data indicate that Rab32 facilitates the phosphorylation of a specific PKA substrate. We uncovered a direct interaction between Rab32 and the adaptor protein optineurin (OPTN), which regulates Golgi dynamics. Further, our data indicate that optineurin is phosphorylated by PKA at Ser342 in a Rab32-dependent manner. Critically, blocking phosphorylation at OPTN Ser342 leads to Golgi fragmentation, and a phospho-mimetic version of OPTN rescues Golgi defects induced by Rab32 L188P. Finally, Rab32 AKAP function and OPTN phosphorylation are required for Golgi repositioning during cell migration, contributing to tumor cell invasion. Together, these data reveal a role for Rab32 in regulating Golgi dynamics through PKA-mediated phosphorylation of OPTN.

Indexed as

Cell MovementCyclic AMP-Dependent Protein KinasesGolgi Apparatusrab GTP-Binding ProteinsTranscription Factor TFIIIACell Cycle ProteinsHeLa CellsHumansMembrane Transport ProteinsPhosphorylationCell Cycle ProteinsCyclic AMP-Dependent Protein KinasesMembrane Transport ProteinsOPTN protein, humanrab GTP-Binding ProteinsTranscription Factor TFIIIAGolgimigrationOptineurinProtein Kinase ARab32

Identifiers

PMID40258145
PMCPMC12054839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.